Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 26.57% |
| Q2 2025 | -10.50% |
| Q1 2025 | -2.70% |
| Q4 2024 | 9.69% |
| Q3 2024 | 5.82% |
| Q2 2024 | -9.41% |
| Q1 2024 | -6.47% |
| Q4 2023 | 3.29% |
| Q3 2023 | 4.84% |
| Q2 2023 | -10.55% |
| Q1 2023 | 9.97% |
| Q4 2022 | -18.11% |
| Q3 2022 | -7.89% |
| Q2 2022 | -27.36% |
| Q1 2022 | 3.99% |
| Q4 2021 | 10.70% |
| Q3 2021 | -45.81% |
| Q2 2021 | 13.19% |
| Q1 2021 | 33.79% |
| Q4 2020 | -116.30% |
| Q3 2020 | -16.25% |
| Q2 2020 | 2.33% |
| Q1 2020 | -22.75% |
| Q4 2019 | -2.53% |
| Q3 2019 | -4.20% |
| Q2 2019 | 2.92% |
| Q1 2019 | 28.63% |
| Q4 2018 | -73.12% |
| Q3 2018 | -3.10% |
| Q2 2018 | -3.24% |
| Q1 2018 | -242.81% |
| Q4 2017 | 37.41% |
| Q3 2017 | -14.63% |
| Q2 2017 | 41.24% |
| Q1 2017 | 18.57% |
| Q4 2016 | -14.14% |
| Q3 2016 | -22.13% |
| Q2 2016 | 13.39% |
| Q1 2016 | -23.20% |
| Q4 2015 | -51.33% |